Research has shown that, compared to other groups, SLE patients—particularly those with lupus nephritis (LN)—exhibit increased NLRP3 inflammasome activation because of significant gain-of-function mutations in the NLRP3 gene [34]. This evidence concerns the gene NLRP3 and systemic lupus erythematosus.